Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Evofem Biosciences, Inc. (EVFM : OTC)
 
 • Company Description   
Evofem Biosciences Inc. develops and anticipates commercializing products which support and promote women as the primary healthcare consumer. The company is identifying and developing new and novel products which specifically address unmet needs in the areas of sexual and reproductive health, the prevention of acquisition of sexually transmitted infections and products which address or promote general health and wellbeing. Evofem Biosciences Inc., formerly known as Neothetics Inc., is based in SAN DIEGO CA.

Number of Employees: 32

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.01 Daily Weekly Monthly
20 Day Moving Average: 268,418 shares
Shares Outstanding: 118.66 (millions)
Market Capitalization: $1.19 (millions)
Beta: -0.92
52 Week High: $0.02
52 Week Low: $0.01
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 4.17% -1.47%
12 Week 5.26% -11.69%
Year To Date 1.01% -5.39%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
7770 Regents Rd Suite 113-618
-
SAN DIEGO,CA 92122
USA
ph: 858-550-1900
fax: 844-828-2010
ir@evofem.com http://www.evofem.com
 
 • General Corporate Information   
Officers
Saundra Pelletier - President; Chief Executive Officer and Interim Cha
Ivy Zhang - Chief Financial Officer and Secretary
Kim P. Kamdar - Director
Tony O'Brien - Director
Colin Rutherford - Director

Peer Information
Evofem Biosciences, Inc. (CORR.)
Evofem Biosciences, Inc. (RSPI)
Evofem Biosciences, Inc. (CGXP)
Evofem Biosciences, Inc. (BGEN)
Evofem Biosciences, Inc. (GTBP)
Evofem Biosciences, Inc. (RGRX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 30048L302
SIC: 2834
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/13/25
Share - Related Items
Shares Outstanding: 118.66
Most Recent Split Date: 5.00 (0.01:1)
Beta: -0.92
Market Capitalization: $1.19 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/13/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: -
Price / Sales: 0.07
EPS Growth
vs. Year Ago Period: 100.00%
vs. Previous Quarter: 100.00%
Sales Growth
vs. Year Ago Period: -76.55%
vs. Previous Quarter: -88.11%
ROE
06/30/25 - -
03/31/25 - -
12/31/24 - -
ROA
06/30/25 - -
03/31/25 - -17.90
12/31/24 - -54.95
Current Ratio
06/30/25 - -
03/31/25 - 0.08
12/31/24 - 0.17
Quick Ratio
06/30/25 - -
03/31/25 - 0.05
12/31/24 - 0.15
Operating Margin
06/30/25 - -
03/31/25 - -18.64
12/31/24 - -45.76
Net Margin
06/30/25 - -
03/31/25 - -18.64
12/31/24 - -45.76
Pre-Tax Margin
06/30/25 - -
03/31/25 - -18.64
12/31/24 - -45.76
Book Value
06/30/25 - -
03/31/25 - -0.61
12/31/24 - -0.63
Inventory Turnover
06/30/25 - -
03/31/25 - 2.21
12/31/24 - 2.84
Debt-to-Equity
06/30/25 - -
03/31/25 - -
12/31/24 - -
Debt-to-Capital
06/30/25 - -
03/31/25 - -
12/31/24 - -
 

Powered by Zacks Investment Research ©